12 Industry Groups

Healthcare, Biotech & Pharma

Industries

Want to know more?

Download here the latest Industry Reports, opinions, and whitepapers.

The Healthcare, Biotech & Pharma industry group report is available for download.

Get in touch

Featured Transaction

Healthcare, Biotech & Pharma

 

More complex challenges in the market and more dynamic changes in people’s lives require more demanding services and more efficient approaches. That’s the DNA of our group.

 

Our market view

The healthcare and pharmaceutical markets are continually developing due to chronic and lifestyle diseases, drug and equipment innovation, and the aging population. Hence, M&A WORLDWIDE and its experts are active in deals from the biotechnology and pharmaceutical sectors as well as a large scope of the life science sector.

We have a strong team of M&A ADVISORS around the world in the Healthcare, Biotech & Pharma industries.

Market Outlook

Players to pursue category leadership
Investment capital to keep the deals flowing in
Oncology remains popular
Life-saving drugs more business attractive

Latest Transactions

Team

Reach us at one of our offices:

Partner

Maurice Koopmans

Director

Alan Kelly

Managing Partner

Cigdem Bicik

Project Manager

Tânia Braga

Partner

Didier Busquet

Managing Partner

Laurent Choppe

Director - Strasbourg

Bertrand Dufay

Analyst Corporate Finance

Tom Moonen

Director

Iwona Penwarden

Corporate Finance Associate Director

Joe Powell

Partner

Marcos Hiran Silva

Managing Director

Eric Yetter

Partner

Dr. Holger Wiemann

Partner

Maurice Koopmans

Experience in M&A for more than 10 years. Involved in 100+ mid-corporate national and international valuations and deals. Industry expertise in Healthcare. ADR-specialist (mediation & negotiation).

Leader of Healthcare, Biotech & Pharma Industry Group.

Industry experience:

Business services; Education and training; Government; Healthcare; Life sciences; Media, printing, and publishing; Real estate & facility management; Recycling; Security; Trade; Wholesale.

Director

Alan Kelly


Chartered Accountant.
Experience in M&A for more than 15 years.
Involved in >mid-corporate national and international deals.
Industry expertise having worked in Commercial Roles in Technology, Distribution & Logistics in international companies.

Co-leader of the Healthcare, Biotech & Pharma Industry Group 

Industry expertise:

Business services; Clean technology; Education and training; Electronics; Energy & renewables; Healthcare; Information technology; Telecom; Transport & logistics.

Managing Partner

Cigdem Bicik

Before founding Crossborder in 2006 Çiğdem worked in the Development and investment banking business for 17 years. She holds an MSc from Loughborough University a BA and MBA in Finance from Istanbul University and is a graduate of the German Gymnasium in Istanbul. She speaks fluent English and German.

Industry experience:

Aerospace & defense; Agriculture; Automotive; Building & construction; Business services; Chemicals; Education and training; Electronics; Energy & renewables; Engineering; Financial services; Food; Government; Hotels & restaurants; Information technology;  Luxury goods; Media, printing, and publishing; Plastics; Real estate & facility management; Retail and franchising; Steel, metal, and woodworking; Telecom; Textile & clothing; Trade; Transport & logistics.
Member of Healthcare Biotech & Pharma Industry Group.

 

Project Manager

Tânia Braga

Experience in various business management and support positions, Tânia is now project manager at Cigno, being in charge of organizing the 32nd M&A Worldwide Convention – Rainmaker Summit in Copenhagen May 2022.

Member of the Healthcare, Biotech & Pharma Industry Group

Partner

Didier Busquet

Didier leverages 29 years of experience and over 90 missions completed. Retail, services, and impact investing specialist.

Member of the Healthcare, Biotech & Pharma Industry Group

Industry experience:

Business services; Education and training; Food; Retail and franchising.

Managing Partner

Laurent Choppe

Laurent leads Cukierman & Co. Life Sciences since 2008 and has been involved in more than 100 Medtech and Biotech corporate finance transactions and advisory assignments for the Cukierman group. His team works worldwide with venture-backed and middle-market companies for fundraising, licensing deals and M&A transactions as well as strategic projects for key life sciences industry players.

Laurent brings extensive international life sciences experience in managing multifunctional teams and setting up new businesses in pharmaceuticals, medical devices, biotechnology, nutraceuticals, animal health and direct-to-consumer markets.

Member of Healthcare, Biotech & Pharma Industry Group

E-mail: telaviv-lifescience@m-a-worldwide.com

Director - Strasbourg

Bertrand Dufay

HSBC Global Banking and Markets: Corporate Coverage for Large Caps (CAC 40 or private groups) with a focus on Automotive (Renault / Michelin) and Healthcare (Sanofi / Servier).BNP Paribas Germany (Corporate & Investment Banking): Corporate Coverage on Mid Caps (Mittelstand)/Emerging Markets.

Industry experience:

Automotive; Healthcare.
Member of Healthcare, Biotech & Pharma Industry Group. 

Analyst Corporate Finance

Tom Moonen

MSF in Finance and BSc in Accounting from Middle Tennessee State University. Former Student-Athlete. Joined Aeternus in 2021.

Member of Healthcare, Biotech & Pharma Industry Group

Director

Iwona Penwarden

16 years experience in corporate finance advisory, ECM, M&A and leading venture capital in Poland. Managing over 50 local and international (ECM, M&A) transaction advisory projects. Managing ECM department awarded by independent organizations in Poland (1st-3rd place among Authorized Advisers in 2010-2013).

Industry experience:

Advertising, PR & marketing; Beverages; Food; Healthcare; Information technology; Insurance; Recycling; Trade.
Member of the Advanced Manufacturing and the Healthcare, Biotech & Pharma Industry Group.

Corporate Finance Associate Director

Joe Powell

Joe joined Rickitt Mitchell in 2021 and during his M&A career to date has advised on several transactions including acquisitions, disposals, PE-Backed MBOs and growth fundraising on the debt market. Recent transactions include the sale of UK based TMT business Spyder to Digital Colony in the US and the sale of Stobart Rail to German PE house, Bavaria Industries.

Member of Healthcare, Biotech & Pharma Industry Group

Industry experience:

Beverages; Energy & renewables; Leisure; Life sciences; Telecom; Transport & logistic.

Partner

Marcos Hiran Silva

Working in financial advisory for 13 years. Previously worked in M&A and strategic planning at Telefonica and Strategy Consulting at Booz Allen Hamilton. BSc. in Mechanical Engineering from Unicamp and MBA degree in General Management from Business School São Paulo (BSP).

Industry experience:

Advertising, PR & marketing; Agriculture; Automotive; Beverages; Chemicals; Electronics; Food; Healthcare; Information technology; Plastics; Retail and franchising; Telecom
Member of Healthcare, Biotech & Pharma Industry Group.

Managing Director

Eric Yetter

Investment banker focused on healthcare. His practice includes healthcare services, outsourced services, medical devices, and healthcare IT. Has completed a variety of healthcare transactions, many with private equity firms and PE-backed companies. His past clients include leading physician groups, healthcare facilities, and institutional healthcare investors.

Founded Physicians First in 2016, recognizing the emerging need for investment banking and advisory services for owners of physician practices, surgery centers and clinical businesses. The next four years saw record levels of physician-owner M&A activity and Physicians First became one of the nation’s most active advisors for transactions between private equity firms and medical practices. In 2021, Eric Yetter agreed to merge Physicians First with FOCUS and lead the firm’s healthcare team.

Also has healthcare operating and investing experience. He was an early executive at Covenant Physician Partners (previously Covenant Surgical Partners), an acquirer and operator of ambulatory surgery centers and physician practices. The company built and operated an outsourced laboratory, an anesthesia business, and a revenue cycle management company. Covenant has grown into a major player in healthcare services and is currently backed by private equity firm KKR.

Prior to Covenant, Eric held operating roles at Volkswagen Group of America and Brainlab, Inc., an image-guided surgery company. While at Brainlab, worked with leading neurosurgeons and hospitals to implement cutting edge technology and improve patient outcomes.

He is a licensed attorney (currently inactive) and earned JD and BS degrees from Vanderbilt University, graduating with high honours; and a FINRA licensed investment banker.

Member of Healthcare, Biotech & Pharma Industry Group.

Partner

Dr. Holger Wiemann

Ph. Economics, Cologne, Munich, Paris.Over 25 years in media, digital, internet, software, health. More than 10 years of tech investments, board positions, consulting & restructuring, national & cross-border M&A. Managing Director and CEO of London, Paris, Corporate P&L responsibility exceeding 3-digit Mill. EUR

Industry experience:

Education and training; Healthcare; Information technology; Media, printing, and publishing.
Member of Healthcare, Biotech & Pharma Industry Group.
Keep up to date — receive our latest news and transactions.